ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

Choosing Between Abiraterone and Novel ARPIs: Practical Insights

Автор: GU Oncology Now

Загружено: 2026-02-20

Просмотров: 60

Описание: A regional roundtable discussion, moderated by Richard Zhang, MD, Fort Wayne Medical Oncology and Hematology, examined evolving treatment strategies across the prostate cancer continuum, including the use of triplet therapy in castration-sensitive disease, sequencing options in castration-resistant disease, and emerging modalities such as radiopharmaceuticals, PARP inhibitors, bispecifics, and novel radioisotopes. Dr. Zhang was joined by other practitioners at Fort Wayne Medical Oncology and Hematology, including Michael Epstein, MD; Ahad Sadiq, MD; Sunil Babu, MD; Ryan Gonzales, MD; and David Zimmerman, MD.

In the second segment, they discussed nuances in PSMA PET imaging, including the differences between gallium-68 and F-18 tracers, and shared how they assess disease risk using PSA, metastasis location, Gleason score, and genetic testing. They also explored management strategies for oligometastatic prostate cancer, including the role of radiation, systemic therapy, intermittent treatment, and sequencing of androgen receptor pathway inhibitors.

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Choosing Between Abiraterone and Novel ARPIs: Practical Insights

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

Overcoming Treatment Challenges in Heavily Pretreated Prostate Cancer

Overcoming Treatment Challenges in Heavily Pretreated Prostate Cancer

Уролог объясняет: 5 признаков рака простаты, которые легко пропустить!

Уролог объясняет: 5 признаков рака простаты, которые легко пропустить!

From Tumor Boards to Trials: Evolving Approaches in Oligometastatic Prostate Cancer

From Tumor Boards to Trials: Evolving Approaches in Oligometastatic Prostate Cancer

Identifying High-Risk Patients: Predictors of Progression to CRPC

Identifying High-Risk Patients: Predictors of Progression to CRPC

Focal Therapy, Functional Imaging, and the Role of AI in Modern Prostate Cancer Care

Focal Therapy, Functional Imaging, and the Role of AI in Modern Prostate Cancer Care

Chemo Free or Chemo First  Navigating Lu-PSMA-617, Radium, and Treatment Sequencing

Chemo Free or Chemo First Navigating Lu-PSMA-617, Radium, and Treatment Sequencing

Navigating Unfavorable IR Disease: Imaging, Staging, and Local Therapy Decisions

Navigating Unfavorable IR Disease: Imaging, Staging, and Local Therapy Decisions

Bridging Local and Metastatic Disease: Salvage Approaches and the Role of Molecular Testing

Bridging Local and Metastatic Disease: Salvage Approaches and the Role of Molecular Testing

Upfront Testing and Monitoring: Practical Approaches in Metastatic Prostate Cancer

Upfront Testing and Monitoring: Practical Approaches in Metastatic Prostate Cancer

Therapy Buckets in Practice: Personalizing Treatment Pathways in Advanced Prostate Cancer

Therapy Buckets in Practice: Personalizing Treatment Pathways in Advanced Prostate Cancer

Dr. Ryan Broderick talks to SurgeOn about his experience with DEXTER

Dr. Ryan Broderick talks to SurgeOn about his experience with DEXTER

Что представляет собой исследование иммунотерапии IL-15 с участием доктора Роба Ребхуна?

Что представляет собой исследование иммунотерапии IL-15 с участием доктора Роба Ребхуна?

Navigating CRPC: PARP Inhibitors, Radioligands, and Sequencing Strategies

Navigating CRPC: PARP Inhibitors, Radioligands, and Sequencing Strategies

PSMA-PET, Genetic Testing, and Imaging Challenges in Early Prostate Cancer

PSMA-PET, Genetic Testing, and Imaging Challenges in Early Prostate Cancer

Case-Based Approaches to Aggressive Disease, Biochemical Recurrence

Case-Based Approaches to Aggressive Disease, Biochemical Recurrence

Next Steps for EV/Pembro: Toxicity Management, ctDNA, and Emerging Trials

Next Steps for EV/Pembro: Toxicity Management, ctDNA, and Emerging Trials

Post-Merger IT Integration: First 30 Days (Day 0 vs Day 1) | John Trchala

Post-Merger IT Integration: First 30 Days (Day 0 vs Day 1) | John Trchala

Как 4000 долларов превзошли 100 000 долларов… История генерального директора о совместимости.

Как 4000 долларов превзошли 100 000 долларов… История генерального директора о совместимости.

Результат КТ| мой выбор УЙТИ ИЗ ЖИЗНИ |

Результат КТ| мой выбор УЙТИ ИЗ ЖИЗНИ |

Как живет парализованный после #монолога

Как живет парализованный после #монолога

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]